← Eichor
Condition: Cardiac Toxicity Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Cardiac Toxicity

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac
Phase 3 · 590 location(s) · SWOG Cancer Research Network · NCT03418961Cardiovascular Health in Adult Patients With Cancer Exposed to Cardiotoxic Therapies
Phase N/A · 1 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT06664528NeoCARD: Anthracycline-Free Neoadjuvant Chemoimmunotherapy in Triple-Negative Breast Cancer Patients
Phase 2 · 1 location(s) · Medical University of South Carolina · NCT06845319Role of Spectral CT in the Evaluation of Cardiotoxicity in Patients With Hodgkin's Lymphoma and Diffuse Large B-cell Lym
Phase N/A · 1 location(s) · IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06774326Cardiovascular Prevention Strategies in Elderly Patients With Cancer (CARTIER Clinical Trial)
NA · 14 location(s) · Fundación Instituto de Estudios de Ciencias de la Salud de C · NCT03711110The CARDIOPROTECT Trial
Phase 2 · 1 location(s) · Beth Israel Deaconess Medical Center · NCT07654426Protective Effects of the Nutritional Supplement Sulforaphane on Doxorubicin-Associated Cardiac Dysfunction
Phase 1/Phase 2 · 1 location(s) · Texas Tech University Health Sciences Center · NCT03934905Metabolic Interventions (Time-Restricted Eating, GLP1 Receptor Agonist, and Heart Healthy Diet) to Improve Cardiometabol
Phase 2 · 1 location(s) · City of Hope Medical Center · NCT07202247RAGE Inhibition to Decrease Cardiotoxicity in Women With Early Breast Cancer
Phase 1/Phase 2 · 3 location(s) · Georgetown University · NCT05256745Cardiotoxicity of Carbon Monoxide in Patients Treated With Hyperbaric Oxygen Therapy
Phase N/A · 1 location(s) · University Hospital, Brest · NCT06549621Sacubitril/Valsartan in PriMAry preventIoN of the Cardiotoxicity of Systematic breaST canceR trEAtMent (MAINSTREAM)
Phase 4 · 4 location(s) · Silesian Centre for Heart Diseases · NCT05465031Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted
Phase 2 · 10 location(s) · Rutgers, The State University of New Jersey · NCT05559164Generation of Heart Muscle Cells From Blood or Skin Cells of Breast Cancer Patients
Phase N/A · 1 location(s) · Memorial Sloan Kettering Cancer Center · NCT02772367Role of Sodium-glucose Linked Transporter 2 (SGLT2) and Its Inhibitor Over CARdiotoxicity Induced by Anthracyclines and
Phase N/A · 1 location(s) · Centre Paul Strauss · NCT06443645Cardiac Magnetic Resonance Monitoring of Immune Checkpoint Inhibitor-related Cardiotoxicity
Phase N/A · 1 location(s) · West China Second University Hospital · NCT06132984Improving the Success Rate for Thoracic Radiotherapy Through Specific Cardiac Substructure Dosimetry: Location Matters.
Phase N/A · 1 location(s) · Fondazione IRCCS Istituto Nazionale dei Tumori, Milano · NCT06361784Breast Cancer Long-term Outcomes on Cardiac Functioning: a Longitudinal Study
Phase N/A · 1 location(s) · University Medical Center Groningen · NCT05851053AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor
Phase N/A · 8 location(s) · Peerbridge Health, Inc · NCT06699056Nicotinamide Riboside and Prevention of Cancer Therapy Related Cardiac Dysfunction in Breast Cancer Patients
Phase 2 · 1 location(s) · University Hospital, Akershus · NCT05732051JUdicious Surveillance for Trastuzumab Induced Cardiotoxicity in the First Year
NA · 1 location(s) · Women's College Hospital · NCT06930521TRUST-ACE - Anticancer-treatment Cardiotoxicity Identification by Echocardiography
NA · 1 location(s) · Norwegian University of Science and Technology · NCT06310330REmote iSchemic condItioning in Lymphoma PatIents REceiving ANthraCyclinEs
NA · 24 location(s) · Fundación Centro Nacional de Investigaciones Cardiovasculare · NCT05223413Acute and Long-term Cardiovascular Toxicity After Modern Radiotherapy for Breast Cancer
Phase N/A · 2 location(s) · St. Olavs Hospital · NCT02541435Early Assessment of Cardiac Function After Treatment With CAR-T Cells
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06350994Cardioprotection on Chemotherapy-Induced Cardiotoxicity
Phase 3 · 2 location(s) · Ain Shams University · NCT06853951Low Dose Rosuvastatin Plus Ezetimibe Versus High-dose Rosuvastatin in AMI
Phase 4 · 7 location(s) · Kiyuk Chang, MD,PhD · NCT04499859At-Home Cardiac Rehabilitation for Adolescents at Risk for Heart Failure
NA · 1 location(s) · Children's Hospital Los Angeles · NCT06826534Evaluation of the Possible Safety and Efficacy of Dapagliflozin in the Prophylaxis of Doxorubicin-Induced Cardiotoxicity
Phase 2 · 1 location(s) · Tanta University · NCT06427226ML Score Prediction of Cardiotoxicity in Cancer Patients Receiving Anthracycline Chemotherapy or HER2-Targeted Therapies
Phase N/A · 1 location(s) · University Hospital, Caen · NCT07191730Imaging Versus Cardiac Biomarker Monitored HER2 Directed Therapy in Patients With Breast Cancer
NA · 4 location(s) · Odense University Hospital · NCT05406635
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.